Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
NNVC
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
These Biotech Stocks Are Cheap Based On 1 Fundamental Measure
With the Federal Reserve lifting interest rates for the first time in more than three years and signalling that money will not be cheap again quickly, investors are being pushed to think harder about where real growth could justify the ris…
Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies?
For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the booming obesity-drug market. But Washington is beginning to shift the conversation. With the U.S. government pushi…
NanoViricides announces $3.8M registered direct offering; shares down
* NanoViricides (NNVC [https://seekingalpha.com/symbol/NNVC]) entered [https://seekingalpha.com/pr/20594541-nanoviricides-announces-pricing-of-3_8-million-registered-direct-offering] into a securities purchase agreement with a single insti…
REPLAY: Fireside Chat with NanoViricides President & Exec. Chairman Anil R. Diwan
Watch Fireside Chat Below, or Click HERE: Exec Edge hosted a fireside chat with NanoViricides, Inc. (NYSE: NNVC) President and Executive Chairman Anil R. Diwan, PhD, moderated by IPO Edge Editor-in-Chief John Jannarone and Editor-at-Large…
Top Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX
(RTTNews) - Today's Top Gainers list features Q32 Bio, which announced a $55 million private placement financing; Soligenix, which is exploring the suitability of its ThermoVax platform to fight the Bundibugyo strain of Ebola virus; P3 Hea…
NanoViricides (NYSE-A:NNVC) announced the closing of its previously disclosed registered direct offering, raising about $2 million in gross proceeds before fees and expenses. The clinical-stage antiviral drug developer sold about 1.3 milli…
Dow, Nasdaq close lower as Treasury yields hit fresh highs
4:20pm: S&P 500 retreats for third straight session Stocks closed lower for a third straight session on Tuesday as rising Treasury yields and lingering inflation concerns continued to pressure equities, pulling the major indexes further aw…
NanoViricides to raise $2M in registered direct offering
NanoViricides (NYSE-A:NNVC) said it has entered into a securities purchase agreement with a single institutional investor for gross proceeds of approximately $2 million in a registered direct offering. Under the terms of the agreement, the…
NanoViricides to Participate at D. Boral Capital Global Conference in NYC
By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said it will participate at the D. Boral Capital Global Conference, to be held on May 7, 2026, at The Plaza Hotel in New York City. The company’s President and Executive Chairman, Anil R. Diw…
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, is pleased to announce that it…
After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers
(RTTNews) - Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates. Zentalis Pha…
NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City
SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicin…
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
Risk is part of investing. Even the most mature, well-established firms and stocks run the risk of declining to zero. However, that risk is even higher with speculative penny stocks. At the same, these less-established firms, with higher r…
NanoViricides shares soar 41% after announcing plans to develop a monkeypox treatment
Shares of NanoViricides Inc. jumped 41.8% in premarket trading on Thursday after the company said it began developing a monkeypox treatment. There are currently no approved or authorized therapies for monkeypox, though the Food and Drug Ad…
Beyond Meat, Inc.’s BYND shares rose 3.4% after the company reported that it is expanding the availability of Beyond Breakfast Sausage Classic Patties range by more than 1,500 Walmart stores. Shares of Red Cat Holdings, Inc. RCAT surged 50…
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Sim…
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterpri…
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and…
Nanoviricides Stock Surges, Nears The End Of A Pennant Pattern
Nanoviricides Inc. (NYSE: NNVC) shares are surging higher Tuesday following news of the company reporting significant advantages gained by remdesivir encapsulation within its lead COVID-19 candidate, thus showing a potential pan-coronaviru…
26 Stocks Moving in Wednesday's Pre-Market Session
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 46.1% to $0.6699 in pre-market trading after dropping 11% on Tuesday. MeaTech 3D Ltd. (NASDAQ: MITC) rose 18.5% to $6.29 in pre-market trading. MeaTech Group said it manufactured over half a kilogra…
Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited (NYSE: OG) jumped 30.6% to close at $7.30 after dropping 18% o…
Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares climbed 25.5% to $6.00. The company on Monday announced interim ana…
Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share. DatChat, Inc. (NASDAQ: DATS) rose 16.2% to $7.60 in pre-market trading after gainin…
The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 8) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) Bausch Health Companies Inc. (NYSE: BHC…
The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 8) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) Bausch Health Companies Inc. (NYSE: BHC…
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 1) Acceleron Pharma Inc. (NASDAQ: XLRN) Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Aslan Pharma…
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 1) Acceleron Pharma Inc. (NASDAQ: XLRN) Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Aslan Pharma…
NanoViricides, Inc. Investors Who Purchased NNVC Securities After January 2020 And Suffered Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
PHILADELPHIA, July 16, 2020 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of NanoViricides, Inc. (“NanoViricides” or the “Company”) (NYSE: NNVC) to determine whether the Compan…
President and Chairman of the Board of Directors, Anil R. Diwan, Ph.D., of NanoViricides, Inc., Discusses Company Updates with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) -- NanoViricides, Inc. (NYSE:NNVC), (the “Company”) announced President and Chairman, Dr. Anil Diwan’s interview on Uptick Newswire’s “Stock Day” Podcast. Everett Jolly invited NanoViricides, Inc.’s…